Manager TitleAgeSince
Chief Executive Officer 63 2022-10-18
President 61 2021-03-28
Comptroller/Controller/Auditor 66 2024-08-11
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 63 -
Director/Board Member 58 2022-03-28
Change 5-day change 1-year change 3-year change Capi.($)
+61.97%+49.35% - - 403K
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average +4.93%-1.58%+27.47%+57.34% 418.21B
Weighted average by Cap. -1.25%-1.89%+30.52%+69.18%
Logo SL Therapeutics, Inc.
SL Therapeutics Inc, formerly Stem Lab Inc, is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of biopharmaceuticals such as stem cell culture mediums, stem cell treatment as well as others.
Employees
-
  1. Stock Market
  2. Stocks
  3. A258540 Stock